Behnoush Khaledian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Behnoush Khaledian has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Yohei Shimono
Department of Biochemistry Fujita Health University School of Medicine Toyoake Aichi Japan
2 shared publications - Eiji Munetsuna
Department of Biochemistry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan
1 shared publication - Fumihiro Sugiyama
University of Tsukuba
1 shared publication Hidehito Inagaki
Fujita Health University Department of Molecular Genetics, Institute for Comprehensive Medical Science Toyoake, Aichi 470-1192 , Japan
1 shared publication- Hiroki Kurahashi
Division of Molecular Genetics, Center for Medical Science, Fujita Health University, Toyoake, Japan
1 shared publication - Hironobu Minami
Division of Medical Oncology and Hematology, Department of Medicine, Kobe University Graduate School of Medicine , 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017
1 shared publication
Latest Publications
- 30 November 2025
- Published by Wiley in Comprehensive Physiology
- Vol. 15 (6) , e70067
Identification of an Intracellular Role for Complement Factor D: Lipid Droplet Biogenesis in Differentiating Adipocytes
Complement factor D (CFD, also known as adipsin) is a secreted serine protease classically known for activating the alternative complement pathway and regulating systemic metabolism. Although CFD is highly expressed in adipocytes, its roles in adipogenesis remain to be elucidated. Here, we show that intracellularly localized CFD promoted lipid droplet (LD) formation in its catalytic activity‐independent manner. Using mammary adipose tissue‐derived stem cells (mADSCs) isolated from wild‐type (WT) and Cfd ‐knockout ( Cfd ‐KO) mice, we demonstrated that the lack of CFD significantly reduced LD number in mature adipocytes. Lentiviral expression of the secretion signal sequence‐deficient (SD) or catalytically inactive CFD mutant, as well as the cytosolic CFD3 splice variant, rescued LD formation to WT levels in Cfd ‐KO adipocytes. In contrast, exogenously supplemented CFD proteins were unable to restore LD formation in our culture system. These findings uncover a previously unrecognized intracellular function for CFD, revealing its regulatory role in LD biogenesis during adipocyte differentiation.
- 30 November 2025
- Published by Wiley in Comprehensive Physiology
- Vol. 15 (6) , e70067
Identification of an Intracellular Role for Complement Factor D: Lipid Droplet Biogenesis in Differentiating Adipocytes
Complement factor D (CFD, also known as adipsin) is a secreted serine protease classically known for activating the alternative complement pathway and regulating systemic metabolism. Although CFD is highly expressed in adipocytes, its roles in adipogenesis remain to be elucidated. Here, we show that intracellularly localized CFD promoted lipid droplet (LD) formation in its catalytic activity‐independent manner. Using mammary adipose tissue‐derived stem cells (mADSCs) isolated from wild‐type (WT) and Cfd ‐knockout ( Cfd ‐KO) mice, we demonstrated that the lack of CFD significantly reduced LD number in mature adipocytes. Lentiviral expression of the secretion signal sequence‐deficient (SD) or catalytically inactive CFD mutant, as well as the cytosolic CFD3 splice variant, rescued LD formation to WT levels in Cfd ‐KO adipocytes. In contrast, exogenously supplemented CFD proteins were unable to restore LD formation in our culture system. These findings uncover a previously unrecognized intracellular function for CFD, revealing its regulatory role in LD biogenesis during adipocyte differentiation.
- 25 November 2022
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 32 (8) , 1301-1312
Antisense oligonucleotide induced pseudoexon skipping and restoration of functional protein for Fukuyama muscular dystrophy caused by a deep-intronic variant
Fukuyama congenital muscular dystrophy (FCMD) is an autosomal recessive disorder caused by fukutin (FKTN) gene mutations. FCMD is the second most common form of childhood muscular dystrophy in Japan, and the most patients possess a homozygous retrotransposal SINE-VNTR-Alu insertion in the 3′-untranslated region of FKTN. A deep-intronic variant (DIV) was previously identified as the second most prevalent loss-of-function mutation in Japanese patients with FCMD. The DIV creates a new splicing donor site in intron 5 that causes aberrant splicing and the formation of a 64-base pair pseudoexon in the mature mRNA, resulting in a truncated nonfunctional protein. Patients with FCMD carrying the DIV present a more severe symptoms, and currently, there is no radical therapy available for this disorder. In the present study, we describe in vitro evaluation of antisense oligonucleotide mediated skipping of pseudoexon inclusion and restoration of functional FKTN protein. A total of 16 19-26-mer antisense oligonucleotide sequences were designed with a 2’-O-methyl backbone and were screened in patient-derived fibroblasts, lymphoblast cells, and minigene splice assays. One antisense oligonucleotide targeting the exonic splice enhancer region significantly induced pseudoexon skipping and increased the expression of normal mRNA. It also rescued FKTN protein production in lymphoblast cells and restored functional O-mannosyl glycosylation of alpha-dystroglycan in patient-derived myotubes. Based on our results, ASO-based splicing correction should be investigated further as a potential treatment for patients with FCMD carrying the DIV.
- 25 November 2022
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 32 (8) , 1301-1312
Antisense oligonucleotide induced pseudoexon skipping and restoration of functional protein for Fukuyama muscular dystrophy caused by a deep-intronic variant
Fukuyama congenital muscular dystrophy (FCMD) is an autosomal recessive disorder caused by fukutin (FKTN) gene mutations. FCMD is the second most common form of childhood muscular dystrophy in Japan, and the most patients possess a homozygous retrotransposal SINE-VNTR-Alu insertion in the 3′-untranslated region of FKTN. A deep-intronic variant (DIV) was previously identified as the second most prevalent loss-of-function mutation in Japanese patients with FCMD. The DIV creates a new splicing donor site in intron 5 that causes aberrant splicing and the formation of a 64-base pair pseudoexon in the mature mRNA, resulting in a truncated nonfunctional protein. Patients with FCMD carrying the DIV present a more severe symptoms, and currently, there is no radical therapy available for this disorder. In the present study, we describe in vitro evaluation of antisense oligonucleotide mediated skipping of pseudoexon inclusion and restoration of functional FKTN protein. A total of 16 19-26-mer antisense oligonucleotide sequences were designed with a 2’-O-methyl backbone and were screened in patient-derived fibroblasts, lymphoblast cells, and minigene splice assays. One antisense oligonucleotide targeting the exonic splice enhancer region significantly induced pseudoexon skipping and increased the expression of normal mRNA. It also rescued FKTN protein production in lymphoblast cells and restored functional O-mannosyl glycosylation of alpha-dystroglycan in patient-derived myotubes. Based on our results, ASO-based splicing correction should be investigated further as a potential treatment for patients with FCMD carrying the DIV.
- Open Access
Adipsin-Dependent Secretion of Hepatocyte Growth Factor Regulates the Adipocyte-Cancer Stem Cell Interaction
Adipose tissue is a component of the tumor microenvironment and is involved in tumor progression. We have previously shown that adipokine adipsin (CFD) functions as an enhancer of tumor proliferation and cancer stem cell (CSC) properties in breast cancers. We established the Cfd-knockout (KO) mice and the mammary adipose tissue-derived stem cells (mADSCs) from them. Cfd-KO in mADSCs significantly reduced their ability to enhance tumorsphere formation of breast cancer patient-derived xenograft (PDX) cells, which was restored by the addition of Cfd in the culture medium. Hepatocyte growth factor (HGF) was expressed and secreted from mADSCs in a Cfd-dependent manner. HGF rescued the reduced ability of Cfd-KO mADSCs to promote tumorsphere formation in vitro and tumor formation in vivo by breast cancer PDX cells. These results suggest that HGF is a downstream effector of Cfd in mADSCs that enhances the CSC properties in breast cancers.
Open AccessAdipsin-Dependent Secretion of Hepatocyte Growth Factor Regulates the Adipocyte-Cancer Stem Cell Interaction
Adipose tissue is a component of the tumor microenvironment and is involved in tumor progression. We have previously shown that adipokine adipsin (CFD) functions as an enhancer of tumor proliferation and cancer stem cell (CSC) properties in breast cancers. We established the Cfd-knockout (KO) mice and the mammary adipose tissue-derived stem cells (mADSCs) from them. Cfd-KO in mADSCs significantly reduced their ability to enhance tumorsphere formation of breast cancer patient-derived xenograft (PDX) cells, which was restored by the addition of Cfd in the culture medium. Hepatocyte growth factor (HGF) was expressed and secreted from mADSCs in a Cfd-dependent manner. HGF rescued the reduced ability of Cfd-KO mADSCs to promote tumorsphere formation in vitro and tumor formation in vivo by breast cancer PDX cells. These results suggest that HGF is a downstream effector of Cfd in mADSCs that enhances the CSC properties in breast cancers.